Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FP81U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,817
Award facts
- Contract value 100% obligated
- $33,816.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,816.51 delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML pen injections on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. KESIMPTA (ofatumumab) is a monoclonal antibody immunosuppressant indicated for treating relapsing forms of multiple sclerosis, reflecting the Defense Logistics Agency's role in supplying specialized pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's competitive position as a major pharmaceutical distributor and critical vendor in the federal medical procurement space is reinforced through its successful track record of fulfilling federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FP81U?
SPE2DB25FP81U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FP81U worth?
The government has obligated $33,817 on SPE2DB25FP81U.
Is contract SPE2DB25FP81U an order under another contract?
Yes. SPE2DB25FP81U is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP81U competed?
The extent of competition for SPE2DB25FP81U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award